Medical Care
Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2024
- Jan 20, 24
- ID: 12043
- Pages: 96
- Figures: 188
- Views: 34
The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases.
The global Viral Vectors and Plasmid DNA Manufacturing market was valued at US$ 608 million in 2023 and is anticipated to reach US$ 1961.9 million by 2030, witnessing a CAGR of 18.0% during the forecast period 2024-2030.
Global Viral Vectors and Plasmid DNA Manufacturing key players include BioReliance, Oxford BioMedica, UniQure, Cobra Biologics, etc. Global top four manufacturers hold a share over 45%.
North America is the largest market, with a share about 50%, followed by Asia-Pacific, and Europe, both have a share over 40 percent.
In terms of product, Viral Vectors is the largest segment, with a share about 80%. And in terms of application, the largest application is Cancers, followed by Inherited Disorders, Viral Infections , etc.
This report aims to provide a comprehensive presentation of the global market for Viral Vectors and Plasmid DNA Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vectors and Plasmid DNA Manufacturing.
Report Scope
The Viral Vectors and Plasmid DNA Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral Vectors and Plasmid DNA Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Vectors and Plasmid DNA Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory
Segment by Type
Plasmid DNA
Viral Vectors
Segment by Application
Cancers
Inherited Disorders
Viral Infections
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Vectors and Plasmid DNA Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Viral Vectors and Plasmid DNA Manufacturing market was valued at US$ 608 million in 2023 and is anticipated to reach US$ 1961.9 million by 2030, witnessing a CAGR of 18.0% during the forecast period 2024-2030.
Global Viral Vectors and Plasmid DNA Manufacturing key players include BioReliance, Oxford BioMedica, UniQure, Cobra Biologics, etc. Global top four manufacturers hold a share over 45%.
North America is the largest market, with a share about 50%, followed by Asia-Pacific, and Europe, both have a share over 40 percent.
In terms of product, Viral Vectors is the largest segment, with a share about 80%. And in terms of application, the largest application is Cancers, followed by Inherited Disorders, Viral Infections , etc.
This report aims to provide a comprehensive presentation of the global market for Viral Vectors and Plasmid DNA Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vectors and Plasmid DNA Manufacturing.
Report Scope
The Viral Vectors and Plasmid DNA Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral Vectors and Plasmid DNA Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Vectors and Plasmid DNA Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory
Segment by Type
Plasmid DNA
Viral Vectors
Segment by Application
Cancers
Inherited Disorders
Viral Infections
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Vectors and Plasmid DNA Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Plasmid DNA
1.2.3 Viral Vectors
1.3 Market by Application
1.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancers
1.3.3 Inherited Disorders
1.3.4 Viral Infections
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Perspective (2019-2030)
2.2 Viral Vectors and Plasmid DNA Manufacturing Growth Trends by Region
2.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Region (2019-2024)
2.2.3 Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Region (2025-2030)
2.3 Viral Vectors and Plasmid DNA Manufacturing Market Dynamics
2.3.1 Viral Vectors and Plasmid DNA Manufacturing Industry Trends
2.3.2 Viral Vectors and Plasmid DNA Manufacturing Market Drivers
2.3.3 Viral Vectors and Plasmid DNA Manufacturing Market Challenges
2.3.4 Viral Vectors and Plasmid DNA Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Revenue
3.1.1 Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Revenue (2019-2024)
3.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Vectors and Plasmid DNA Manufacturing Revenue
3.4 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio
3.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2023
3.5 Viral Vectors and Plasmid DNA Manufacturing Key Players Head office and Area Served
3.6 Key Players Viral Vectors and Plasmid DNA Manufacturing Product Solution and Service
3.7 Date of Enter into Viral Vectors and Plasmid DNA Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vectors and Plasmid DNA Manufacturing Breakdown Data by Type
4.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Type (2019-2024)
4.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (2025-2030)
5 Viral Vectors and Plasmid DNA Manufacturing Breakdown Data by Application
5.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Application (2019-2024)
5.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size (2019-2030)
6.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2019-2024)
6.4 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size (2019-2030)
7.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2019-2024)
7.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size (2019-2030)
8.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2019-2024)
8.4 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size (2019-2030)
9.2 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2019-2024)
9.4 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size (2019-2030)
10.2 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2019-2024)
10.4 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioReliance
11.1.1 BioReliance Company Detail
11.1.2 BioReliance Business Overview
11.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Introduction
11.1.4 BioReliance Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.1.5 BioReliance Recent Development
11.2 Cobra Biologics
11.2.1 Cobra Biologics Company Detail
11.2.2 Cobra Biologics Business Overview
11.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Introduction
11.2.4 Cobra Biologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.2.5 Cobra Biologics Recent Development
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Detail
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Introduction
11.3.4 Oxford BioMedica Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.3.5 Oxford BioMedica Recent Development
11.4 UniQure
11.4.1 UniQure Company Detail
11.4.2 UniQure Business Overview
11.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Introduction
11.4.4 UniQure Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.4.5 UniQure Recent Development
11.5 FinVector
11.5.1 FinVector Company Detail
11.5.2 FinVector Business Overview
11.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Introduction
11.5.4 FinVector Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.5.5 FinVector Recent Development
11.6 MolMed
11.6.1 MolMed Company Detail
11.6.2 MolMed Business Overview
11.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Introduction
11.6.4 MolMed Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.6.5 MolMed Recent Development
11.7 MassBiologics
11.7.1 MassBiologics Company Detail
11.7.2 MassBiologics Business Overview
11.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Introduction
11.7.4 MassBiologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.7.5 MassBiologics Recent Development
11.8 Richter-Helm
11.8.1 Richter-Helm Company Detail
11.8.2 Richter-Helm Business Overview
11.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Introduction
11.8.4 Richter-Helm Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.8.5 Richter-Helm Recent Development
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Introduction
11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.10 Lonza
11.10.1 Lonza Company Detail
11.10.2 Lonza Business Overview
11.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Introduction
11.10.4 Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.10.5 Lonza Recent Development
11.11 Aldevron
11.11.1 Aldevron Company Detail
11.11.2 Aldevron Business Overview
11.11.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Introduction
11.11.4 Aldevron Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.11.5 Aldevron Recent Development
11.12 Eurogentec
11.12.1 Eurogentec Company Detail
11.12.2 Eurogentec Business Overview
11.12.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Introduction
11.12.4 Eurogentec Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.12.5 Eurogentec Recent Development
11.13 Cell and Gene Therapy Catapult
11.13.1 Cell and Gene Therapy Catapult Company Detail
11.13.2 Cell and Gene Therapy Catapult Business Overview
11.13.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Introduction
11.13.4 Cell and Gene Therapy Catapult Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.13.5 Cell and Gene Therapy Catapult Recent Development
11.14 Biovian
11.14.1 Biovian Company Detail
11.14.2 Biovian Business Overview
11.14.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Introduction
11.14.4 Biovian Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.14.5 Biovian Recent Development
11.15 Thermo Fisher Scientific (Brammer Bio)
11.15.1 Thermo Fisher Scientific (Brammer Bio) Company Detail
11.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
11.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Introduction
11.15.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Development
11.16 VGXI
11.16.1 VGXI Company Detail
11.16.2 VGXI Business Overview
11.16.3 VGXI Viral Vectors and Plasmid DNA Manufacturing Introduction
11.16.4 VGXI Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.16.5 VGXI Recent Development
11.17 PlasmidFactory
11.17.1 PlasmidFactory Company Detail
11.17.2 PlasmidFactory Business Overview
11.17.3 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Introduction
11.17.4 PlasmidFactory Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.17.5 PlasmidFactory Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Plasmid DNA
1.2.3 Viral Vectors
1.3 Market by Application
1.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancers
1.3.3 Inherited Disorders
1.3.4 Viral Infections
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Perspective (2019-2030)
2.2 Viral Vectors and Plasmid DNA Manufacturing Growth Trends by Region
2.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Region (2019-2024)
2.2.3 Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Region (2025-2030)
2.3 Viral Vectors and Plasmid DNA Manufacturing Market Dynamics
2.3.1 Viral Vectors and Plasmid DNA Manufacturing Industry Trends
2.3.2 Viral Vectors and Plasmid DNA Manufacturing Market Drivers
2.3.3 Viral Vectors and Plasmid DNA Manufacturing Market Challenges
2.3.4 Viral Vectors and Plasmid DNA Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Revenue
3.1.1 Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Revenue (2019-2024)
3.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Vectors and Plasmid DNA Manufacturing Revenue
3.4 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio
3.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2023
3.5 Viral Vectors and Plasmid DNA Manufacturing Key Players Head office and Area Served
3.6 Key Players Viral Vectors and Plasmid DNA Manufacturing Product Solution and Service
3.7 Date of Enter into Viral Vectors and Plasmid DNA Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vectors and Plasmid DNA Manufacturing Breakdown Data by Type
4.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Type (2019-2024)
4.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (2025-2030)
5 Viral Vectors and Plasmid DNA Manufacturing Breakdown Data by Application
5.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Application (2019-2024)
5.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size (2019-2030)
6.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2019-2024)
6.4 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size (2019-2030)
7.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2019-2024)
7.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size (2019-2030)
8.2 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2019-2024)
8.4 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size (2019-2030)
9.2 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2019-2024)
9.4 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size (2019-2030)
10.2 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2019-2024)
10.4 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioReliance
11.1.1 BioReliance Company Detail
11.1.2 BioReliance Business Overview
11.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Introduction
11.1.4 BioReliance Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.1.5 BioReliance Recent Development
11.2 Cobra Biologics
11.2.1 Cobra Biologics Company Detail
11.2.2 Cobra Biologics Business Overview
11.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Introduction
11.2.4 Cobra Biologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.2.5 Cobra Biologics Recent Development
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Detail
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Introduction
11.3.4 Oxford BioMedica Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.3.5 Oxford BioMedica Recent Development
11.4 UniQure
11.4.1 UniQure Company Detail
11.4.2 UniQure Business Overview
11.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Introduction
11.4.4 UniQure Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.4.5 UniQure Recent Development
11.5 FinVector
11.5.1 FinVector Company Detail
11.5.2 FinVector Business Overview
11.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Introduction
11.5.4 FinVector Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.5.5 FinVector Recent Development
11.6 MolMed
11.6.1 MolMed Company Detail
11.6.2 MolMed Business Overview
11.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Introduction
11.6.4 MolMed Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.6.5 MolMed Recent Development
11.7 MassBiologics
11.7.1 MassBiologics Company Detail
11.7.2 MassBiologics Business Overview
11.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Introduction
11.7.4 MassBiologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.7.5 MassBiologics Recent Development
11.8 Richter-Helm
11.8.1 Richter-Helm Company Detail
11.8.2 Richter-Helm Business Overview
11.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Introduction
11.8.4 Richter-Helm Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.8.5 Richter-Helm Recent Development
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Introduction
11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.10 Lonza
11.10.1 Lonza Company Detail
11.10.2 Lonza Business Overview
11.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Introduction
11.10.4 Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.10.5 Lonza Recent Development
11.11 Aldevron
11.11.1 Aldevron Company Detail
11.11.2 Aldevron Business Overview
11.11.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Introduction
11.11.4 Aldevron Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.11.5 Aldevron Recent Development
11.12 Eurogentec
11.12.1 Eurogentec Company Detail
11.12.2 Eurogentec Business Overview
11.12.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Introduction
11.12.4 Eurogentec Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.12.5 Eurogentec Recent Development
11.13 Cell and Gene Therapy Catapult
11.13.1 Cell and Gene Therapy Catapult Company Detail
11.13.2 Cell and Gene Therapy Catapult Business Overview
11.13.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Introduction
11.13.4 Cell and Gene Therapy Catapult Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.13.5 Cell and Gene Therapy Catapult Recent Development
11.14 Biovian
11.14.1 Biovian Company Detail
11.14.2 Biovian Business Overview
11.14.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Introduction
11.14.4 Biovian Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.14.5 Biovian Recent Development
11.15 Thermo Fisher Scientific (Brammer Bio)
11.15.1 Thermo Fisher Scientific (Brammer Bio) Company Detail
11.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
11.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Introduction
11.15.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Development
11.16 VGXI
11.16.1 VGXI Company Detail
11.16.2 VGXI Business Overview
11.16.3 VGXI Viral Vectors and Plasmid DNA Manufacturing Introduction
11.16.4 VGXI Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.16.5 VGXI Recent Development
11.17 PlasmidFactory
11.17.1 PlasmidFactory Company Detail
11.17.2 PlasmidFactory Business Overview
11.17.3 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Introduction
11.17.4 PlasmidFactory Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
11.17.5 PlasmidFactory Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Plasmid DNA
Table 3. Key Players of Viral Vectors
Table 4. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2019-2024)
Table 8. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2025-2030)
Table 10. Viral Vectors and Plasmid DNA Manufacturing Market Trends
Table 11. Viral Vectors and Plasmid DNA Manufacturing Market Drivers
Table 12. Viral Vectors and Plasmid DNA Manufacturing Market Challenges
Table 13. Viral Vectors and Plasmid DNA Manufacturing Market Restraints
Table 14. Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Players (2019-2024)
Table 16. Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors and Plasmid DNA Manufacturing as of 2023)
Table 17. Ranking of Global Top Viral Vectors and Plasmid DNA Manufacturing Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Viral Vectors and Plasmid DNA Manufacturing Product Solution and Service
Table 21. Date of Enter into Viral Vectors and Plasmid DNA Manufacturing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2019-2024)
Table 25. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2025-2030)
Table 27. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application (2019-2024)
Table 29. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application (2025-2030)
Table 31. North America Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 46. BioReliance Company Detail
Table 47. BioReliance Business Overview
Table 48. BioReliance Viral Vectors and Plasmid DNA Manufacturing Product
Table 49. BioReliance Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 50. BioReliance Recent Development
Table 51. Cobra Biologics Company Detail
Table 52. Cobra Biologics Business Overview
Table 53. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product
Table 54. Cobra Biologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 55. Cobra Biologics Recent Development
Table 56. Oxford BioMedica Company Detail
Table 57. Oxford BioMedica Business Overview
Table 58. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product
Table 59. Oxford BioMedica Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 60. Oxford BioMedica Recent Development
Table 61. UniQure Company Detail
Table 62. UniQure Business Overview
Table 63. UniQure Viral Vectors and Plasmid DNA Manufacturing Product
Table 64. UniQure Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 65. UniQure Recent Development
Table 66. FinVector Company Detail
Table 67. FinVector Business Overview
Table 68. FinVector Viral Vectors and Plasmid DNA Manufacturing Product
Table 69. FinVector Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 70. FinVector Recent Development
Table 71. MolMed Company Detail
Table 72. MolMed Business Overview
Table 73. MolMed Viral Vectors and Plasmid DNA Manufacturing Product
Table 74. MolMed Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 75. MolMed Recent Development
Table 76. MassBiologics Company Detail
Table 77. MassBiologics Business Overview
Table 78. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product
Table 79. MassBiologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 80. MassBiologics Recent Development
Table 81. Richter-Helm Company Detail
Table 82. Richter-Helm Business Overview
Table 83. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product
Table 84. Richter-Helm Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 85. Richter-Helm Recent Development
Table 86. FUJIFILM Diosynth Biotechnologies Company Detail
Table 87. FUJIFILM Diosynth Biotechnologies Business Overview
Table 88. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product
Table 89. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 90. FUJIFILM Diosynth Biotechnologies Recent Development
Table 91. Lonza Company Detail
Table 92. Lonza Business Overview
Table 93. Lonza Viral Vectors and Plasmid DNA Manufacturing Product
Table 94. Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 95. Lonza Recent Development
Table 96. Aldevron Company Detail
Table 97. Aldevron Business Overview
Table 98. Aldevron Viral Vectors and Plasmid DNA Manufacturing Product
Table 99. Aldevron Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 100. Aldevron Recent Development
Table 101. Eurogentec Company Detail
Table 102. Eurogentec Business Overview
Table 103. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product
Table 104. Eurogentec Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 105. Eurogentec Recent Development
Table 106. Cell and Gene Therapy Catapult Company Detail
Table 107. Cell and Gene Therapy Catapult Business Overview
Table 108. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product
Table 109. Cell and Gene Therapy Catapult Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 110. Cell and Gene Therapy Catapult Recent Development
Table 111. Biovian Company Detail
Table 112. Biovian Business Overview
Table 113. Biovian Viral Vectors and Plasmid DNA Manufacturing Product
Table 114. Biovian Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 115. Biovian Recent Development
Table 116. Thermo Fisher Scientific (Brammer Bio) Company Detail
Table 117. Thermo Fisher Scientific (Brammer Bio) Business Overview
Table 118. Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product
Table 119. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 120. Thermo Fisher Scientific (Brammer Bio) Recent Development
Table 121. VGXI Company Detail
Table 122. VGXI Business Overview
Table 123. VGXI Viral Vectors and Plasmid DNA Manufacturing Product
Table 124. VGXI Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 125. VGXI Recent Development
Table 126. PlasmidFactory Company Detail
Table 127. PlasmidFactory Business Overview
Table 128. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product
Table 129. PlasmidFactory Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 130. PlasmidFactory Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Type: 2023 VS 2030
Figure 3. Plasmid DNA Features
Figure 4. Viral Vectors Features
Figure 5. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Application: 2023 VS 2030
Figure 7. Cancers Case Studies
Figure 8. Inherited Disorders Case Studies
Figure 9. Viral Infections Case Studies
Figure 10. Others Case Studies
Figure 11. Viral Vectors and Plasmid DNA Manufacturing Report Years Considered
Figure 12. Global Viral Vectors and Plasmid DNA Manufacturing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Viral Vectors and Plasmid DNA Manufacturing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region: 2023 VS 2030
Figure 15. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Players in 2023
Figure 16. Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors and Plasmid DNA Manufacturing as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2023
Figure 18. North America Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2019-2030)
Figure 20. United States Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2019-2030)
Figure 24. Germany Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2019-2030)
Figure 32. China Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2019-2030)
Figure 40. Mexico Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2019-2030)
Figure 44. Turkey Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. BioReliance Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 47. Cobra Biologics Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 48. Oxford BioMedica Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 49. UniQure Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 50. FinVector Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 51. MolMed Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 52. MassBiologics Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 53. Richter-Helm Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 54. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 55. Lonza Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 56. Aldevron Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 57. Eurogentec Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 58. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 59. Biovian Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 60. Thermo Fisher Scientific (Brammer Bio) Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 61. VGXI Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 62. PlasmidFactory Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Plasmid DNA
Table 3. Key Players of Viral Vectors
Table 4. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2019-2024)
Table 8. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2025-2030)
Table 10. Viral Vectors and Plasmid DNA Manufacturing Market Trends
Table 11. Viral Vectors and Plasmid DNA Manufacturing Market Drivers
Table 12. Viral Vectors and Plasmid DNA Manufacturing Market Challenges
Table 13. Viral Vectors and Plasmid DNA Manufacturing Market Restraints
Table 14. Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Players (2019-2024)
Table 16. Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors and Plasmid DNA Manufacturing as of 2023)
Table 17. Ranking of Global Top Viral Vectors and Plasmid DNA Manufacturing Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Viral Vectors and Plasmid DNA Manufacturing Product Solution and Service
Table 21. Date of Enter into Viral Vectors and Plasmid DNA Manufacturing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2019-2024)
Table 25. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2025-2030)
Table 27. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application (2019-2024)
Table 29. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application (2025-2030)
Table 31. North America Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 46. BioReliance Company Detail
Table 47. BioReliance Business Overview
Table 48. BioReliance Viral Vectors and Plasmid DNA Manufacturing Product
Table 49. BioReliance Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 50. BioReliance Recent Development
Table 51. Cobra Biologics Company Detail
Table 52. Cobra Biologics Business Overview
Table 53. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product
Table 54. Cobra Biologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 55. Cobra Biologics Recent Development
Table 56. Oxford BioMedica Company Detail
Table 57. Oxford BioMedica Business Overview
Table 58. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product
Table 59. Oxford BioMedica Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 60. Oxford BioMedica Recent Development
Table 61. UniQure Company Detail
Table 62. UniQure Business Overview
Table 63. UniQure Viral Vectors and Plasmid DNA Manufacturing Product
Table 64. UniQure Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 65. UniQure Recent Development
Table 66. FinVector Company Detail
Table 67. FinVector Business Overview
Table 68. FinVector Viral Vectors and Plasmid DNA Manufacturing Product
Table 69. FinVector Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 70. FinVector Recent Development
Table 71. MolMed Company Detail
Table 72. MolMed Business Overview
Table 73. MolMed Viral Vectors and Plasmid DNA Manufacturing Product
Table 74. MolMed Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 75. MolMed Recent Development
Table 76. MassBiologics Company Detail
Table 77. MassBiologics Business Overview
Table 78. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product
Table 79. MassBiologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 80. MassBiologics Recent Development
Table 81. Richter-Helm Company Detail
Table 82. Richter-Helm Business Overview
Table 83. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product
Table 84. Richter-Helm Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 85. Richter-Helm Recent Development
Table 86. FUJIFILM Diosynth Biotechnologies Company Detail
Table 87. FUJIFILM Diosynth Biotechnologies Business Overview
Table 88. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product
Table 89. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 90. FUJIFILM Diosynth Biotechnologies Recent Development
Table 91. Lonza Company Detail
Table 92. Lonza Business Overview
Table 93. Lonza Viral Vectors and Plasmid DNA Manufacturing Product
Table 94. Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 95. Lonza Recent Development
Table 96. Aldevron Company Detail
Table 97. Aldevron Business Overview
Table 98. Aldevron Viral Vectors and Plasmid DNA Manufacturing Product
Table 99. Aldevron Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 100. Aldevron Recent Development
Table 101. Eurogentec Company Detail
Table 102. Eurogentec Business Overview
Table 103. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product
Table 104. Eurogentec Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 105. Eurogentec Recent Development
Table 106. Cell and Gene Therapy Catapult Company Detail
Table 107. Cell and Gene Therapy Catapult Business Overview
Table 108. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product
Table 109. Cell and Gene Therapy Catapult Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 110. Cell and Gene Therapy Catapult Recent Development
Table 111. Biovian Company Detail
Table 112. Biovian Business Overview
Table 113. Biovian Viral Vectors and Plasmid DNA Manufacturing Product
Table 114. Biovian Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 115. Biovian Recent Development
Table 116. Thermo Fisher Scientific (Brammer Bio) Company Detail
Table 117. Thermo Fisher Scientific (Brammer Bio) Business Overview
Table 118. Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product
Table 119. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 120. Thermo Fisher Scientific (Brammer Bio) Recent Development
Table 121. VGXI Company Detail
Table 122. VGXI Business Overview
Table 123. VGXI Viral Vectors and Plasmid DNA Manufacturing Product
Table 124. VGXI Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 125. VGXI Recent Development
Table 126. PlasmidFactory Company Detail
Table 127. PlasmidFactory Business Overview
Table 128. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product
Table 129. PlasmidFactory Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024) & (US$ Million)
Table 130. PlasmidFactory Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Type: 2023 VS 2030
Figure 3. Plasmid DNA Features
Figure 4. Viral Vectors Features
Figure 5. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Application: 2023 VS 2030
Figure 7. Cancers Case Studies
Figure 8. Inherited Disorders Case Studies
Figure 9. Viral Infections Case Studies
Figure 10. Others Case Studies
Figure 11. Viral Vectors and Plasmid DNA Manufacturing Report Years Considered
Figure 12. Global Viral Vectors and Plasmid DNA Manufacturing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Viral Vectors and Plasmid DNA Manufacturing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Region: 2023 VS 2030
Figure 15. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Players in 2023
Figure 16. Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors and Plasmid DNA Manufacturing as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2023
Figure 18. North America Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2019-2030)
Figure 20. United States Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2019-2030)
Figure 24. Germany Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Share by Region (2019-2030)
Figure 32. China Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2019-2030)
Figure 40. Mexico Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Share by Country (2019-2030)
Figure 44. Turkey Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Viral Vectors and Plasmid DNA Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. BioReliance Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 47. Cobra Biologics Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 48. Oxford BioMedica Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 49. UniQure Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 50. FinVector Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 51. MolMed Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 52. MassBiologics Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 53. Richter-Helm Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 54. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 55. Lonza Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 56. Aldevron Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 57. Eurogentec Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 58. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 59. Biovian Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 60. Thermo Fisher Scientific (Brammer Bio) Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 61. VGXI Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 62. PlasmidFactory Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232